Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that data from an investigator-initiated Phase II trial conducted at Memorial Sloan Kettering Cancer Center will be ...
Basis of design for the city’s third phase of downtown revitalization, which will renovate First Avenue from Pine Street to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results